| Product Name | Ouabain-d3 (Major) |
| Product Code | DA-O075-a |
| Chemical name | Ouabain-d3 (Major) |
| Synonyms | (1β,3β,5β,11α)-3-[(6-Deoxy-α-L-mannopyranosyl)oxy]-1,5,11,14,19-pentahydroxycard-20(22)-enolide-d3; g-Strophanthin-d3; |
| Impurity | NA |
| CAS Number | NA |
| Alternate CAS # | NA |
| Molecular form | C29H41D3O12 |
| Appearance | White Solid |
| Melting Point | NA |
| Mol. Weight | 587.67 |
| Storage | 2-8°C Hygroscopic, Refrigerator, Under Inert Atmosphere |
| Solubility | NA |
| Stability | NA |
| Category | carbohydrates,heterocycles,enzyme inhibitors,stable isotopes,pharmaceutical standards,intermediates,fine chemicals,steroids |
| Boiling Point | NA |
| Applications | Labelled Ouabain. A cardiac glycoside that inhibits Na(+)/K(+) ATPase. It regulates transcription of MDR (increase, Pgp) and MRP (increase MRP1 and decrease CFTR, cyctic fibrosis transport receptor or cAMP-activated Cl- channel) genes, also alters localization of MRP1. |
| Dangerous Goods Info | NA |
| References | NA |
| Extra Notes | NA |
| Documents (MSDS) | No Data Available |
| Keywords | NA |
